Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Indacaterol vs Tiotropium on Inspiratory Capacity in Moderate COPD
NCT00999908Phase 3Completed
- Sponsor
- Novartis
- Start
- Oct 2009
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of indacaterol in chronic obstructive pulmonary disease (COPD), sponsored by Novartis. Started Oct 2009; status: completed.
02
Drugs
indacaterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00999908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00999908.